Thurston Springer Miller Herd & Titak’s ARK Genomic Revolution ETF ARKG Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.13K	Buy	+217	New	+$6.91K	﹤0.01%	861
2025 Q3	–	Sell	-44	Closed	-$1.08K	–	584
2025 Q2	$1.08K	Hold	44	–	–	﹤0.01%	1491
2025 Q1	$919	Buy	+44	New	+$1.1K	﹤0.01%	1528
2024 Q2	–	Sell	-92	Closed	-$2.66K	–	1564
2024 Q1	$2.66K	Buy	+92	New	+$2.77K	﹤0.01%	136

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ARKG Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 217 shares worth $9.13K. The stake represents ﹤0.01% of the portfolio and ranks #861 among its holdings. This is a return to the name: Thurston Springer Miller Herd & Titak previously reported a position in ARKG as recently as Q2 2025.

Thurston Springer Miller Herd & Titak first reported a position in ARKG in Q1 2024 and has held it in 4 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Thurston Springer Miller Herd & Titak held 217 shares of ARK Genomic Revolution ETF worth $9.13K as of Q2 2026.
ARK Genomic Revolution ETF was a new Thurston Springer Miller Herd & Titak position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #861 holding.
Thurston Springer Miller Herd & Titak first reported a position in ARK Genomic Revolution ETF in Q1 2024 and has held it in 4 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.